Study on Neurodevelopmental Outcomes After In Utero Lyme Disease Exposure Launched
A pilot study has been initiated to evaluate the neurodevelopmental outcomes of infants exposed to Lyme disease in utero.
Phase III
Infectious Disease / Lyme Disease
Status
Initiated
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This study is significant as it explores the neurodevelopmental impact of Lyme disease exposure in utero, which could lead to new treatment guidelines and risk assessments for affected pregnancies. The findings may influence clinical practices and therapeutic strategies in the infectious disease domain.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor recruitment progress and initial findings on neurodevelopmental assessments over the next 18 months.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.